Apply for the Fellow-in-Training Board Position
Have a fellow-in-training aspiring to lead? Refer them to apply for the fellow-in-training (FIT) board position. The deadline to apply for the FIT board position has passed.
AACT Position Statements
The AACT Board of Trustees may consider endorsing high quality position statements and/or other documents that advance the missing of the organization. More Information
Submit your case for the CPC today!
CPC Submission Deadline: June 3, 2024 The American College of Medical Toxicology (ACMT) is proud to announce the 25th Clinical Pathological Case Presentation Competition (or CPC) in association with North American Congress of Clinical Toxicology (NACCT) annual toxicology conference in Denver, Colorado. The CPC competition is expected to be…
Seeking Nominees for 2024 AACT National Election
Dear AACT Member, We are seeking nominations for key leadership positions within the AACT. The applications of prospective nominees will be reviewed and a final ballot will be assembled by the AACT Board of Trustees. The following positions are available: President-Elect (1) Treasurer (1) Trustees (3)…
NACCT 2024: Accepting Abstracts
Deadline to submit an abstract is May 9. Submit an Abstract for NACCT 2024
AACT National Book Club: Save these Dates
AACT National Book Club Dates April 16, 2024 – Poisoner in Chief, Stephen Kizner July 16, 2024 – A History of War in Six Drugs, Peter Andreas NACCT 2024 – Blitz: Drugs in the Third Reich, Norman Ohler January 14, 2024 – TBD Register
ACMT & AACT Joint Position Statement on Nalmefene
Nalmefene should not replace naloxone as the primary opioid antidote at this time. Read the entire statement here.
Question of the Day – Monday, November 13, 2023
Why would insufflation or inhalation of a single vial of powdered onabotulinumtoxinA (Botox®) be unlikely to cause systemic botulism? OnabotulinumtoxinA is supplied in 50 and 100 unit vials. There is 0.73 ng of botulinum toxin A per 100 units of onabotulinumtoxinA. It is estimated that…
Question of the Day – Friday, November 10, 2023
Failure of dopamine to produce vasoconstriction in the setting of disulfiram use results from inhibition of what enzyme? Dopamine beta-hydroxylase, a copper containing enzyme, is responsible for the conversion of dopamine to norepinephrine. Disulfiram and diethyldithiocarbamate are copper chelators. By inhibition of dopamine beta-hydroxylate, this…